|
1. |
Flat-Elevated Colorectal Neoplasms Exhibit a High Malignant Potential |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 89-93
Claudio Rolim Teixeira,
Shinji Tanaka,
Ken Haruma,
Masaharu Yoshihara,
Koji Sumii,
Goro Kajiyama,
Fumio Shimamoto,
Preview
|
PDF (2449KB)
|
|
摘要:
The potential of flat-elevated colorectal adenomas to undergo rapid malignant transformation and progression to invasive carcinoma is still under discussion. Therefore, a total of 130 colorectal neoplastic lesions ≥ 1 cm in diameter were examined after endoscopic or surgical resection. Lesions were macroscopically classified into three categories: (1) flat elevation (22 lesions), superficially elevated lesion with a smooth surface; (2) granular laterally spreading tumor (GLST; 26 lesions), laterally spreading aggregates of nodules forming a lesion with granular surface, and (3) polypoid (82 lesions), pedunculated, sub-pedunculated and sessile polyps. The adenomatous component showed a tubulovillous architecture in 9/26 (35%) of GLST and 18/82 (22%) of polypoid lesions, however none of the flat-elevated lesions had a villous component (p < 0.01; p < 0.05). Carcinoma was present in 17/22 (77%) flat elevations, 37/82 (45%) polypoid lesions and 11/26 (42%) GLST (p < 0.05). None of the carcinomas arising in GLST and only 1/37 (3%) of those developing in polypoid lesions were invasive carcinomas, but 4/17 (24%) carcinomas arising in flat elevations showed submucosal invasion. Moreover, while all 5 noncancerous flat elevations showed severe atypia, 17/82 (21%) polypoid lesions and 5/26 (19%) GLST showed moderate atypia. In conclusion, flat-elevated colorectal neoplasms have a high malignant potential and the role of these lesions as precursors ofcolorectal carcinomas deserves greater emphasi
ISSN:0030-2414
DOI:10.1159/000227542
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
2. |
Association of Testicular Non-Hodgkin’s Lymphomas with Elevated Serum Levels of Human Chorionic Gonadotropin-Like Material |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 94-98
Michael B. Møller,
Preview
|
PDF (2464KB)
|
|
摘要:
Serum β-human chorionic gonadotropin (S-β-hCG) is a widely used tumor marker in patients with testicular neoplasia. When elevated in patients with an enlarged testis it is considered as a strong indication of a germ cell tumor. Elevation of S-hCG-like material (S-hCG-1) has been reported in nontesticular non-germ cell tumors including non-Hodgkin’s lymphomas (NHL) as well. It has never been investigated whether testicular NHL is also associated with elevated S-hCG-1. In the present study the relationship of testicular NHL with increased S-hCG-1 was investigated. In the Danish population-based NHL registry, LYFO registry, 12 cases with testicular involvement of the lymphoma at the time of diagnosis and that had S-hCG-1 measured prior to treatment were identified, and cases with elevated S-hCG-1 were analyzed clinicopatho-logically. Of these, 2 patients had elevated levels. Both cases were high-grade, diffuse B-cell NHL in elderly patients. The patients were hemiorchiectomized and after surgery levels of S-hCG-1 declined to normal. The study indicates that S-hCG-1 elevation is quite frequently associated with testicular NHL. The prognostic significance of this elevation remains to be investigated, as does the usefulness of S-hCG-1 as tumor marker for early detection of recurrences and for monitoring the therapy of patients with S-hCG-1-positive
ISSN:0030-2414
DOI:10.1159/000227543
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
3. |
Expression of c-fmsProto-Oncogene Product by Ovarian Cancer Cell Lines with Effects of Macrophage Colony-Stimulating Factor on Proliferation |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 99-103
Mitsuaki Suzuki,
Isao Sekiguchi,
Michitaka Ohwada,
Ikuo Sato,
Tomohiko Matsui,
Toshizumi Tanabe,
Shinichi Hashimoto,
Muneo Yamada,
Preview
|
PDF (2045KB)
|
|
摘要:
We studied the production of macrophage colony-stimulating factor (M-CSF) and the expression of c-fms mRNA, an M-CSF receptor, in four human ovarian cancer cell lines. All four cell lines expressed c-fms mRNA while three secreted M-CSF into the culture medium. The exogenous administration of M-CSF caused no significant enhancement of cellular proliferation in any cell line. Interestingly, the proliferation of KK cells was not affected by anti-M-CSF antibody. These results, taken together with the fact that ovarian cancer cells simultaneously produce M-CSF and c-fms, suggest that an autocrine mechanism may modulate cellular proliferation.
ISSN:0030-2414
DOI:10.1159/000227544
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
4. |
Prognostic Value of Immunohistochemical Expression of p53 in Patients with Pancreatic Cancer |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 104-111
J. Lundin,
S. Nordling,
K. von Boguslawsky,
P.J. Roberts,
C. Haglund,
Preview
|
PDF (1875KB)
|
|
摘要:
The prognostic value of the immunohistochemical expression of p53 was evaluated in 133 patients with pancreatic cancer. Formalin-fixed paraffin-embedded specimens of ductal pancreatic adenocarcinomas retrieved at the time of operation were stained with the monoclonal antibody DO-7. Approximately half of the tumors (47%) showed a high level of p53 immunoreactivity (≥ 20% positive nuclei). No correlation was demonstrated between the level of p53 immunoreactivity and age of the patient, gender, TNM stage, resectability or site of the tumor. A high level of p53 staining was seen in a slightly smaller proportion (30%) of patients with well-differentiated tumors than in patients with moderately (50%) or poorly differentiated (50%) tumors, but the difference was not significant. In a multivariate survival analysis, stage, grade and postoperative chemotherapy emerged as independent prognostic factors. Surgical resectability, if entered instead of stage as a variable in a separate Cox model, predicted prognosis independently. In univariate analysis, the site of the tumor was also a significant prognostic variable. However, no association between the level of p53 immunoreactivity and survival in either uni- or multivariate analysis was foun
ISSN:0030-2414
DOI:10.1159/000227545
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
5. |
Immunohistochemical Expression of Metallothionein in Invasive Breast Cancer in Relation to Proliferative Activity, Histology and Prognosis |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 112-117
Tetsunari Oyama,
Hiroyuki Takei,
Toshiaki Hikino,
Yuichi Iino,
Takashi Nakajima,
Preview
|
PDF (2541KB)
|
|
摘要:
Immunohistochemically detected metallothionein expression [MT(+)] was shown to be related to aggressive behavior of the invasive ductal carcinoma of the breast. In this study, MT expression was examined immunohistochemically in 92 cases of invasive breast carcinoma and compared with immunohistochemically demonstrated estrogen receptor (ER), c-erbB-2, Ki-67 status and clinocopathological characteristics. Of the 92 cases examined, 27.1% (25 cases) were MT(+), and high percentages of the solid tubular subtype of invasive ductal carcinoma (47%), medullary carcinoma (80%), and carcinomas with spindle cell metaplasia (100%) were positive for MT. MT(+) carcinomas showed tendency to have highly atypical nuclei, and nuclear staining for Ki-67 antigen was found in a higher percentage of cases than in MT(––) carcinomas. An inverse relationship between MT(+) and ER immunoreactivity was observed. MT expression was not associated with age distribution, menopausal status, tumor size or lymph node metastasis. The overall survival rate in MT(+) cases was worse than in those negative for MT, but no significant association was found. MT(+) was not associated with poor prognosis in total, estrogen receptor-negative or node-negative tumors. These findings suggest that MT expression in breast cancer cells is related to cell-proliferative activity, and that dedifferentiation of carcinoma cells may play a role in induction of MT express
ISSN:0030-2414
DOI:10.1159/000227546
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
6. |
Mucin mRNA Expression in Lung Adenocarcinoma Cell Lines and Tissues |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 118-126
Chong-Jen Yu,
Pan-Chyr Yang,
Jin-Yuh Shew,
Tse-Ming Hong,
Schuenn-Chen Yang,
Yung-Chie Lee,
Li-Na Lee,
Kwen-Tay Luh,
Cheng-Wen Wu,
Preview
|
PDF (1994KB)
|
|
摘要:
The expression pattern of mucin genes was studied in 7 lung adenocarcinoma cell lines (CL1, CL2, CL3, NCL2, PC9, PC13, PC14) and 12 lung adenocarcinoma tissues. CL1 and PC 13 are poorly differentiated cell lines with low mucin glycoprotein production. The other 5 cell lines are well differentiated and produce a higher amount of mucins. Total RNA was extracted from these cell lines. Northern blot analysis was performed by hybridization with specific antisense oligonucleotide probes recognizing mucin-specific tandem repeats of 4 mucin genes (MUC1, MUC2, MUC3, MUC4). RT-PCR was carried out to amplify the 3′ and 5′ nonrepetitive coding regions of MUC1 and the 5’ nonrepetitive coding region of MUC2. All these cell lines expressed MUC1, MUC2, MUC3, and MUC4 mRNA but in variable mounts. The poorly differentiated cell lines (CL1 and PC 13) had a relatively low level of expression of MUC1, MUC2, MUC3 and MUC4. RT-PCR, with primers amplifying the MUC1 nonrepetitive coding region 5′ end, 293 bp, and the 3′ end, 522 bp, as well as the MUC2 nonrepetitive 5′ coding region, 308 bp, revealed the presence of MUC1 and MUC2 mRNA in all the cell lines. Sequence analysis of the PCR products were very homologous, similar to previously published MUC1 and MUC2 cDNA sequences. The expression pattern of mucin genes is consistent with that of mucin glycoproteins as studied using biochemical and immunological methods. Northern blotting and RT-PCR analysis in 12 lung adenocarcinoma tissues with various grades of differentiation (6 poorly differentiated adenocarcinomas and 6 moderately to well-differentiated adenocarcinomas) showed heterogeneous expression of the 4 mucin genes in tissues without clear correlation with the differentiation grade. Therefore the clinical implications of the differential expression of the mucin genes need further in
ISSN:0030-2414
DOI:10.1159/000227547
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
7. |
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1): A Potential Prognostic Marker Involved in Leukocyte Infiltration of Renal Cell Carcinoma |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 127-132
Gerasimos Anastassiou,
Stefan Duensing,
Gustav Steinhoff,
Ulrich Zorn,
Jens Grosse,
Iris Dallmann,
Hartmut Kirchner,
Arnold Ganser,
Jens Atzpodien,
Preview
|
PDF (2481KB)
|
|
摘要:
We investigated immunohistochemically the leukocyte infiltrate [CD3, CD4, CD8, CD11a, CD11b, CD14, CD56, VLA-4 and platelet endothelial cell adhesion molecule-1 (PECAM-1)] and the endothelial expression of cell adhesion molecules (PECAM-1, VCAM-1, ICAM-1 and ICAM-2) in 23 renal cell carcinoma tumor tissues. Tumors with a moderate or high density of PECAM-1-positive endothelia showed a stronger infiltration with PECAM-1-positive leukocytes as compared to tumors with a low density of positive endothelia (p < 0.0085). Additionally, overall survival of patients who presented with tumors exhibiting a moderate or high density of PECAM-1 endothelia alone or in combination with a PECAM-1-positive infiltrate was extended (median survival: 23.5 months) as compared to patients without these tumor characteristics (median survival: 6.5 months). These results suggest an involvement of PECAM-1 in the process of leukocyte migration and a potential role as a prognostic marker in renal cell carcinoma.
ISSN:0030-2414
DOI:10.1159/000227548
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
8. |
Inhibitory Effect of Alkane-6,8-Diols, the Components of Safflower, on Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate in Two-Stage Carcinogenesis in Mouse Skin |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 133-136
Ken Yasukawa,
Toshihiro Akihisa,
Yoshimasa Kasahara,
Tomohiro Kaminaga,
Hiroshi Kanno,
Kunio Kumaki,
Toshitake Tamura,
Michio Takido,
Preview
|
PDF (1571KB)
|
|
摘要:
Erythro-alkane-6,8-diols were isolated from the flowers of Carthamus tinctorius. 12-0-Tetradecanoylphorbol-13-acetate (TPA, 1 ug/ear), a tumor-promoting agent, was applied to the ears of mice to induce inflammation. Of 8 alkane-6,8-diols assayed, the C27, C31, C32, C33 and C35 alkane diols inhibited the inflammation. The 50% inhibitory dose of these compounds for TPA-induced inflammation was 0.5–0.7 mg/ear. However, C21, C23 and C25 alkane-6,8-diols were found to have no effect. Furthermore, the mixture of erythro-alkane-6,8-diols from the flowers of C. tinctorius markedly suppressed the promoting effect of TPA on skin tumor formation in mice following initiation with 7,12-dimethylbenz[a]anthracen
ISSN:0030-2414
DOI:10.1159/000227549
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
9. |
Cyclophosphamide, Mitoxantrone, Fluorouracil versus Conventional CMF as Adjuvant Treatment in Node-Positive Breast Cancer Patients |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 137-146
G. Fountzilas,
A. Polichronis,
K. Katsohis,
K. Gennatas,
D. Toussis,
D. Skarlos,
P. Kosmidis,
S. Vassilaros,
C. Semoglou,
T. Giannakakis,
E. Fahantidis,
G. Klouvas,
N. Tsavaris,
C. Konstantaras,
P. Makrantonakis,
C. Kolotas,
N. Zamboglou,
S. Tsiliakos,
D. Hainoglou,
N. Mylonakis,
N. Pavlidis,
Preview
|
PDF (2088KB)
|
|
摘要:
362 evaluable node-positive patients with stage II breast cancer were randomized, receiving either 6 cycles of conventional CMF or 6 cycles of the combination of cyclophosphamide (500 mg/m2), mitoxantrone (Novantrone 10 mg/ m2), and fluorouracil (500 mg/m2; CNF). After a median follow-up of 51 months, 64 (36%) patients relapsed in the CMF group and 60 (33%) in the CNF group (p = 0.8276). By Cox multivariate analysis, tumor size, menopausal status and number of involved nodes were retained as independently significant variables. Toxicities were remarkably similar in both groups. It appears that after a median follow-up of 51 months there is no significant difference in relapse-free survival between node-positive patients with breast cancer who received either 6 cycles of the conventional CMF or the CNF combination as adjuvant treatment.
ISSN:0030-2414
DOI:10.1159/000227550
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
10. |
Vasoacting Agents Flavone Acetic Acid and Hydralazine Given in Combination Enhance Antitumor Effects under Condition of Hyperthermia |
|
Oncology,
Volume 53,
Issue 2,
1996,
Page 147-152
Manabu Yamamoto,
Tetsuya Kusumoto,
Kazuya Endo,
Hideo Baba,
Yoshihisa Sakaguchi,
Yoshihiko Maehara,
Keizo Sugimachi,
Preview
|
PDF (2661KB)
|
|
摘要:
The combined effects of flavone acetic acid (FAA), hydralazine (HYD) and hyperthermia on B16 melanoma cells and solid tumor were examined in vitro and in vivo. In vitro, hyperthermia did not enhance the cytotoxicity of the combined use of FAA and HYD. In vivo, growth inhibition of B16 melanoma solid tumor by FAA (150 mg/kg) combined with HYD (5.0 mg/kg) could not be differentiated from that by FAA or HYD alone. Increased antitumor effect was recognized when FAA combined with HYD was used under conditions of hyperthermia. FAA combined with HYD significantly reduced tumor blood flow compared to FAA alone or HYD alone. We thus conclude that the significant reduction in tumor blood flow may play an important role in the enhanced antitumor effects of the combined treatment with FAA, HYD, and hyperthermia.
ISSN:0030-2414
DOI:10.1159/000227551
出版商:S. Karger AG
年代:1996
数据来源: Karger
|
|